Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | CRVL | DHT |
|---|---|---|
| Price | $76.00 | $23.82 |
| Change today | ▲ 0.70% | ▲ 0.59% |
| Market cap | $3.84B | $3.84B |
| Return, 3 months | +18.1% | +47.0% |
| Return, year to date | +12.3% | +121.1% |
| Return, 1 year | +1.9% | +132.3% |
| P/E (TTM) | 33.8 | 8.1 |
| P/B | 9.4 | 2.9 |
| P/E percentile vs own 5y | – | 25th |
| Dividend yield | – | 6.17% |
| Revenue growth (YoY, latest qtr) | – | -12.8% |
| Net profit growth (YoY) | – | +16.3% |
| Gross margin | – | 38.3% |
| Operating margin | – | 34.5% |
| Net margin | – | 42.3% |
| Return on equity | – | – |
| Analyst target vs. price | – | -1.3% |
| Analyst buy share | – | 50% |
| RSI (14) | 72 | 72 |
| 30-day volatility | 22.4% | 37.7% |
| Max drawdown, 1 year | -42.6% | -17.2% |
| Trend read | Strong uptrend | Strong uptrend |
| Analyst consensus | – | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
